77925-80-5

Basic information

• Product Name: N-(Benzyloxy)-2-nitrobenzenesulfonaMide
• Synonyms: N-(Benzyloxy)-2-nitrobenzenesulfonaMide
• CAS NO: 77925-80-5
• Molecular Formula: C₁₃H₁₂N₂O₅S
• Molecular Weight: 308.30978
• Mol File: 77925-80-5.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: N-(Benzyloxy)-2-nitrobenzenesulfonaMide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(Benzyloxy)-2-nitrobenzenesulfonaMide(77925-80-5)
• EPA Substance Registry System: N-(Benzyloxy)-2-nitrobenzenesulfonaMide(77925-80-5)

Safety Data

• Hazardous Substances Data: 77925-80-5(Hazardous Substances Data)

Usage

General Description

N-(Benzyloxy)-2-nitrobenzenesulfonamide is a chemical compound that belongs to the category of benzenesulfonamides. It is an organic compound that consists of a sulfonamide group attached to a nitrobenzene ring, with a benzyloxy group attached to the nitrogen atom. This chemical has the potential to be used as a building block in organic synthesis, particularly in the formation of biologically active molecules and pharmaceuticals. Additionally, it has been reported to exhibit inhibitory activity against certain enzymes and could have potential applications in medicinal chemistry. Its unique chemical structure and properties make it a valuable compound for research and development in various fields of chemistry and pharmacology.

Upstream product

• 2687-43-6 O-benzylhydoxylamine hydrochloride 
• 1694-92-4 2-Nitrobenzenesulfonyl chloride 
• 622-33-3 N-benzyloxyamine 

Downstream Products

• 1048037-17-7 C₂₃H₁₉N₃O₇S 

Relevant articles and documents

Endo-Hydroxamic Acid Monomers for the Assembly of a Suite of Non-native Dimeric Macrocyclic Siderophores Using Metal-Templated Synthesis

An expedited synthesis of endo-hydroxamic acid aminocarboxylic acid (endo-HXA) compounds has been developed. These monomeric ligands are relevant to the synthesis of metal-macrocycle complexes using metal-templated synthesis (MTS), and the downstream production of apomacrocycles. Macrocycles can display useful drug properties and be used as ligands for radiometals in medical imaging applications, which supports methodological advances in accessing this class of molecule. Six endo-HXA ligands were prepared that contained methylene groups, ether atoms, or thioether atoms in different regions of the monomer (1-6). MTS using a 1:2 Fe(III)/ligand ratio furnished six dimeric hydroxamic acid macrocycles complexed with Fe(III) (1a-6a). The corresponding apomacrocycles (1b-6b) were produced upon treatment with diethylenetriaminepentaacetic acid (DTPA). Constitutional isomers of the apomacrocycles that contained one ether oxygen atom in the diamine-containing (2b) or dicarboxylic acid-containing (3b) region were well resolved by reverse-phase high-performance liquid chromatography (RP-HPLC). Density functional theory calculations were used to compute the structures and solvated molecular properties of 1b-6b and showed that the orientation of the amide bonds relative to the pseudo-C2 axis was close to parallel in 1b, 2b, and 4b-6b but tended toward perpendicular in 3b. This conformational constraint in 3b reduced the polarity compared with 2b, consistent with the experimental trend in polarity observed using RP-HPLC. The improved synthesis of endo-HXA ligands allows expanded structural diversity in MTS-derived macrocycles and the ability to modulate macrocycle properties.

Total Synthesis and Antimicrobial Activity of Chlorocatechelin A

Chlorocatechelin A (1) is a structurally unique microbial siderophore containing two units of 4-chloro-2,3-dihydroxybenzoic acid (CDB) and a characteristic acylguanidine structure. Purification from the microbe culture is not an easy task due to the labil

1,2,4-OXADIAZOLE AND 1,2,4-THIADIAZOLE BETA-LACTAMASE INHIBITORS

β-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D β-lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.